BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Biotech Bay

  Here Are the Top 10 In Vitro Diagnostic Companies

  The companies are ranked by revenues of clinical diagnostic test instruments, reagents and supplies.

  October 31, 2017

   · 

  2 min read
• Business

  Zymo Research and VWR Team Up in Strategic Supplier Partnership

  The management at Zymo Research announced today a joint agreement with VWR to sell and distribute Zymo Research’s DNA purification, RNA extraction, microbiomic analysis, and epigenetics products throughout North America.

  October 31, 2017

   · 

  2 min read
• Improved NSAID Gels With 3x Faster Penetration Rates and 48 Hour Sustained Release Developed by Nemaura Pharma

  Sufferers of acute arthritic-related pain using ‘over the counter’ gels to alleviate muscle ache and joint inflammation may be interested in the results of laboratory trials recently carried out by Nemaura Pharma.

  October 31, 2017

   · 

  3 min read
• ANGLE plc: Result of AGM Location

  ANGLE plc, a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

  October 31, 2017

   · 

  3 min read
• Business

  Sarepta Therapeutics Signs Exclusive Global Collaboration With Duke University for Gene Editing CRISPR/Cas9 Technology to Develop New Treatments for Duchenne Muscular Dystrophy (DMD)

  The exclusive license option grants Sarepta rights to Duke intellectual property for CRISPR/Cas9.

  October 31, 2017

   · 

  8 min read
• Business

  Vedantra Pharmaceuticals Extends Research Collaboration With Neon Therapeutics to Develop Novel Cancer Immunotherapies

  Under the extended agreement, Vedantra and Neon will continue to build on research exploring the potential benefits of combining Vedantra’s cutting-edge, lymph node targeting amphiphile technology with Neon’s innovative capabilities in neoantigen vaccine research.

  October 31, 2017

   · 

  3 min read
• Policy

  Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products

  The Brazilian Ministério da Saúde issued regulatory approvals for seven of Sonoma’s non-steroidal and non-antibiotic topical dermatology products.

  October 31, 2017

   · 

  5 min read
• Median Technologies Adds MediScan to Its Product Portfolio

  Median Technologies intends to leverage Mediscan for strengthening the commercial development and market penetration of its application portfolio in Asia and more specifically in China.

  October 31, 2017

   · 

  3 min read
• Business

  Protalix BioTherapeutics to Hold Third Quarter 2017 Financial Results and Corporate Update Conference Call on November 8, 2017

  The company will provide a corporate update on Wednesday, November 8, 2017 at 8:30 am ET.

  October 31, 2017

   · 

  2 min read
• Drug Development

  Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

  The data supports clinical development of MB-103 HER2 CAR T cell therapy.

  October 31, 2017

   · 

  4 min read